A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study (Q35013760)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study |
scientific article |
Statements
1 reference
A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study (English)
1 reference
Robert L Coleman
1 reference
William E Brady
1 reference
D Scott McMeekin
1 reference
Peter G Rose
1 reference
John T Soper
1 reference
Samuel S Lentz
1 reference
James S Hoffman
1 reference
Mark S Shahin
1 reference
15 April 2011
1 reference
1 reference
122
1 reference
1
1 reference
111-115
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference